Skip to content

Drug interactions

Erlotinib + Tucatinib

Severity: Moderate

Erlotinib and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib is a CYP3A inhibitor and may increase exposure to erlotinib. This could heighten erlotinib toxicity.

What this interaction means in plain words

Erlotinib and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Erlotinib belongs to Oncology; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 metabolism of erlotinib by tucatinib.

What to do

Avoid if possible. If used together, monitor for erlotinib adverse effects and reduce the dose in 50 mg steps for severe toxicity.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erlotinib and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erlotinib with Tucatinib?

MediHelp rates the interaction as moderate. Erlotinib and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib is a CYP3A inhibitor and may increase exposure to erlotinib. This could heighten erlotinib toxicity.

How serious is the interaction between Erlotinib and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If used together, monitor for erlotinib adverse effects and reduce the dose in 50 mg steps for severe toxicity.

What other medicines interact with Erlotinib?

MediHelp also lists interactions of Erlotinib with, for example, Amobarbital, Apalutamide, Carbamazepine. The full list is on the Erlotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in